KP
MDT icon

Keel Point’s Medtronic MDT Stock Holding History

Keel Point’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$303K Sell
3,499
-2,151
-38% -$206K 0.02% 351
2025
Q4 		$543K Buy
5,650
+521
+10% +$50.6K 0.03% 279
2025
Q3 		$489K Sell
5,129
-176
-3% -$16.2K 0.03% 305
2025
Q2 		$462K Buy
5,305
+1,354
+34% +$115K 0.03% 314
2025
Q1 		$355K Buy
3,951
+1,385
+54% +$124K 0.03% 319
2024
Q4 		$205K Buy
+2,566
New +$222K 0.02% 413
2023
Q4 		– Sell
-3,735
Closed -$293K – 358
2023
Q3 		$293K Sell
3,735
-574
-13% -$48.1K 0.04% 242
2023
Q2 		$380K Buy
4,309
+369
+9% +$31.8K 0.05% 204
2023
Q1 		$318K Buy
3,940
+251
+7% +$20.5K 0.05% 214
2022
Q4 		$287K Sell
3,689
-1,075
-23% -$87.1K 0.05% 221
2022
Q3 		$385K Sell
4,764
-27
-0.6% -$2.43K 0.07% 165
2022
Q2 		$451K Buy
4,791
+217
+5% +$22K 0.07% 155
2022
Q1 		$507K Sell
4,574
-32,442
-88% -$3.43M 0.08% 148
2021
Q4 		$3.83M Buy
37,016
+5,384
+17% +$623K 0.43% 50
2021
Q3 		$3.96M Buy
31,632
+2,878
+10% +$373K 0.51% 38
2021
Q2 		$3.57M Buy
28,754
+2,923
+11% +$367K 0.4% 50
2021
Q1 		$3.05M Buy
25,831
+2,907
+13% +$341K 0.3% 54
2020
Q4 		$2.69M Buy
22,924
+3,133
+16% +$345K 0.24% 76
2020
Q3 		$2.06M Buy
19,791
+4,319
+28% +$434K 0.19% 79
2020
Q2 		$1.42M Buy
15,472
+709
+5% +$68K 0.15% 80
2020
Q1 		$1.33M Buy
14,763
+415
+3% +$44.2K 0.17% 59
2019
Q4 		$1.63M Buy
14,348
+2,186
+18% +$240K 0.18% 57
2019
Q3 		$1.32M Sell
12,162
-430
-3% -$44.9K 0.16% 62
2019
Q2 		$1.23M Buy
12,592
+2,341
+23% +$214K 0.14% 66
2019
Q1 		$934K Buy
10,251
+2,598
+34% +$233K 0.11% 77
2018
Q4 		$696K Buy
7,653
+4,259
+125% +$398K 0.09% 89
2018
Q3 		$334K Buy
3,394
+558
+20% +$51.6K 0.04% 136
2018
Q2 		$243K Buy
+2,836
New +$237K 0.03% 146

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Keel Point's MDT Position: Q1 2026 in Review

Keel Point reduced its Medtronic (MDT) stake by 38% in Q1 2026, selling an estimated $206K and leaving 3,499 shares worth $303K. The position accounts for 0.02% of the portfolio, ranked #351.

Keel Point first reported a position in MDT in Q2 2018 and has held it in 28 quarters since. The position peaked at $3.96M in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Keel Point held 3,499 shares of Medtronic worth $303K as of Q1 2026.
  • Keel Point sold 2,151 Medtronic shares in Q1 2026, an estimated $206K.
  • Medtronic made up 0.02% of Keel Point's portfolio in Q1 2026, its #351 holding.
  • Keel Point first reported a position in Medtronic in Q2 2018 and has held it in 28 quarters since.
  • Keel Point's Medtronic position peaked at $3.96M in Q3 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Keel Point's 13F filing for Q1 2026, filed 1 Jun 2026.